Nutex Health (NUTX) Proxy Filing summary

Executive summary

• Annual meeting scheduled for April 23, 2026, with voting available online or virtually.

• Shareholders are encouraged to review proxy materials and vote by April 22, 2026.

Voting matters and shareholder proposals

• Election of seven directors is on the agenda, with board recommendations provided for each nominee.

• Advisory vote on executive compensation is included.

• Ratification of Grant Thornton LLP as independent registered public accounting firm for 2026 is proposed.

• Other business may be addressed as appropriate during the meeting.

Board of directors and corporate governance

• Nominees for director positions are Thomas T. Vo, Warren Hosseinion, Cheryl Grenas, Michael L. Reed, Scott J. Saunders, Kelvin Spears, and Frank E. Jaumot.